AGREEMENT BY AND BETWEEN REGEN BIOPHARMA, INC. AND ONCOLOGY PHARMA INC.License Agreement • April 13th, 2023 • Regen BioPharma Inc • Pharmaceutical preparations • California
THIS LICENSE AGREEMENT, including the exhibits referred to herein and attached hereto (the “Agreement”), effective as of April 7, 2021 (the “Effective Date”), is made and entered into by and between Regen BioPharma, Inc., a Nevada corporation (“Licensor”) and Oncology Pharma, Inc., a Nevada corporation (“Licensee”). Licensor and Licensee may be referred to in this Agreement each as a “Party” or collectively as the “Parties.”
AGREEMENT BY AND BETWEEN REGEN BIOPHARMA, INC. AND ZANDER THERAPEUTICS, INC.License Agreement • April 13th, 2023 • Regen BioPharma Inc • Pharmaceutical preparations
THIS LICENSE AGREEMENT, including the exhibits referred to herein and attached hereto (the “Agreement”), effective as of June 23, 2015 (the “Effective Date”), is made and entered into by and between Regen BioPharma Inc., an Nevada corporation (“Licensor”) and Zander Therapeutics Inc., a Nevada corporation (“Licensee”). Licensor and Licensee may be referred to in this Agreement each as a “Party” or collectively as the “Parties.”
LICENSE ASSIGNMENT AND CONSENT AGREEMENTLicense Assignment Agreement • April 13th, 2023 • Regen BioPharma Inc • Pharmaceutical preparations
THIS LICENSE ASSIGNMENT AND CONSENT AGREEMENT (this ”Agreement”), is entered into as of December 17, 2018, by and among Zander Therapeutics, Inc. ( “Licensee”), Regen Biopharma, Inc. (“Licensor”) and KCL Therapeutics, Inc. (“Assignee”)
DIRECT OFFERING SUBSCRIPTION AGREEMENTDirect Offering Subscription Agreement • April 13th, 2023 • Regen BioPharma Inc • Pharmaceutical preparations • California
The undersigned (the “Subscriber”), desires to become a holder of shares of common stock (the “Shares”) of REGEN BIOPHARMA, INC, a Nevada corporation (the “Company”), having its principal place of business located at 4700 Spring Street, St 304, La Mesa, California 91942
